CARILION BIOMEDICAL INSTITUTE (EIN 541965057) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

G ROBERT VAUGHAN JR

Phone

5402245137

Tax Period

2023-10-01 to 2024-09-30

CARILION BIOMEDICAL INSTITUTE, founded in 2000, is a micro nonprofit in the Health Care sector that reported $1K in total revenue in fiscal year 2017. Revenue fell 98% from the prior year — a significant decline worth monitoring. Expenses of $221K exceeded revenue, resulting in a 18291% operating deficit.

Mission

CBI'S GOALS ARE TO BECOME A WORLD-CLASS BIOMEDICAL SCIENCE, ENGINEERING AND TECHNOLOGY INSTITUTE, FOCUSED ON RESEARCH AND DEVELOPMENT, PROVIDING SERVICES AND SUPPORT TO VIRGINIA TECH AND CARILION CLINIC, AND TO IMPROVE HEALTHCARE BOTH IN THE UNITED STATES OF AMERICA AND GLOBALLY.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $7,868

Other Revenue $2

TOTAL REVENUE $7,870

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $4,903

Other Expenses $7,004

TOTAL EXPENSES $7,004

Year-over-Year Comparison

	2023	2022	Change
Revenue	$7,870	$6,423	+0.2%
Expenses	$7,004	$6,733	+0.0%
Net Income	$866	$-310	-3.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$616,568

Total Directors

$5,648,667

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
NANCY H AGEE	DIRECTOR	1.00	Director	$0	$1,792	$3,832,498
DONALD B HALLIWILL	DIRECTOR	1.00	Director	$0	$167,911	$1,287,159
G ROBERT VAUGHAN JR	BOARD CHAIRMAN, PRESIDENT	1.00	Officer Director	$0	$71,002	$529,010
BETH A HARBER	SECRETARY/TREASURER	1.00	Officer	$0	$8,528	$87,558

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$7,870	$7,004	$692,509	$866
2023	$6,423	$6,733	$691,493	$-310
2022	$684	$6,618	$660,306	$-5,934
2021	$265	$6,313	$668,467	$-6,048
2020	$470	$8,091	$674,285	$-7,621
2019	$10,139	$32,043	$683,470	$-21,904
2018	$1,200	$220,694	$707,440	$-219,494

CARILION BIOMEDICAL INSTITUTE